NO307686B1 - Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter - Google Patents

Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Info

Publication number
NO307686B1
NO307686B1 NO940008A NO940008A NO307686B1 NO 307686 B1 NO307686 B1 NO 307686B1 NO 940008 A NO940008 A NO 940008A NO 940008 A NO940008 A NO 940008A NO 307686 B1 NO307686 B1 NO 307686B1
Authority
NO
Norway
Prior art keywords
tablet
tablets
preparation
pharmaceutical tablet
colestipol hydrochloride
Prior art date
Application number
NO940008A
Other languages
English (en)
Norwegian (no)
Other versions
NO940008L (no
NO940008D0 (no
Inventor
Robert Wu-Wei Shen
Jeffrey Ellis Price
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO940008L publication Critical patent/NO940008L/no
Publication of NO940008D0 publication Critical patent/NO940008D0/no
Publication of NO307686B1 publication Critical patent/NO307686B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940008A 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter NO307686B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72504491A 1991-07-03 1991-07-03
PCT/US1992/005066 WO1993000915A1 (en) 1991-07-03 1992-06-23 Colestipol hydrochloride high-content tablets

Publications (3)

Publication Number Publication Date
NO940008L NO940008L (no) 1994-01-03
NO940008D0 NO940008D0 (no) 1994-01-03
NO307686B1 true NO307686B1 (no) 2000-05-15

Family

ID=24912923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940008A NO307686B1 (no) 1991-07-03 1994-01-03 Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter

Country Status (18)

Country Link
US (1) US5490987A (de)
EP (1) EP0592594B1 (de)
JP (1) JP3313710B2 (de)
KR (1) KR100240362B1 (de)
AT (1) ATE173931T1 (de)
AU (1) AU669664B2 (de)
CA (1) CA2110166C (de)
CZ (1) CZ286958B6 (de)
DE (1) DE69227773T2 (de)
DK (1) DK0592594T3 (de)
ES (1) ES2124736T3 (de)
FI (1) FI106843B (de)
HU (1) HU222242B1 (de)
NO (1) NO307686B1 (de)
PL (1) PL169045B1 (de)
RU (1) RU2108090C1 (de)
SK (1) SK281920B6 (de)
WO (1) WO1993000915A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
ATE286386T1 (de) * 1999-10-19 2005-01-15 Genzyme Corp Direktkomprimierter tablettenkern auf polymerbasis
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
US7964182B2 (en) * 2006-09-01 2011-06-21 USV, Ltd Pharmaceutical compositions comprising phosphate-binding polymer
CA2749074A1 (en) * 2006-09-01 2008-05-29 Usv Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
BRPI0918499A2 (pt) * 2008-09-02 2015-12-01 Usv Ltd polímeros reticulados
EP2389168A2 (de) * 2009-01-22 2011-11-30 USV Limited Pharmazeutische zusammensetzungen mit einem phosphatbindenden polymer
US9763928B2 (en) * 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803237A (en) * 1969-11-03 1974-04-09 Upjohn Co Reaction products of polyethylenepolyamines and chlorohydrins or epoxy containing compounds
US3692895A (en) * 1970-09-08 1972-09-19 Norman A Nelson Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria
ZA804914B (en) * 1979-08-29 1981-08-26 Rohm & Haas The production of powdered resin and the powdered resin so produced
US4439419A (en) * 1980-02-20 1984-03-27 The Upjohn Company Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin
US4404346A (en) * 1980-08-05 1983-09-13 Rohm And Haas Company Production of powdered resin and the powdered resin so produced
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
CS255081B1 (cs) * 1985-12-21 1988-02-15 Arnost Pospisil Způsob Výroby tablet s časové řízenou liberací obsahující nestálou a/nabo dráidivou fyziologicky aktivní složku
WO1989012452A1 (en) * 1988-06-24 1989-12-28 The Upjohn Company Fine-milled colestipol hydrochloride
IE63242B1 (en) * 1988-06-24 1995-04-05 Abbott Lab Pharmaceutical granules and tablets made therefrom
AU628389B2 (en) * 1988-08-26 1992-09-17 Pharmacia & Upjohn Company Fine-beaded colestipol hydrochloride

Also Published As

Publication number Publication date
RU2108090C1 (ru) 1998-04-10
WO1993000915A1 (en) 1993-01-21
SK281920B6 (sk) 2001-09-11
DE69227773D1 (de) 1999-01-14
FI106843B (fi) 2001-04-30
AU669664B2 (en) 1996-06-20
JP3313710B2 (ja) 2002-08-12
CZ282693A3 (en) 1994-06-15
AU2293392A (en) 1993-02-11
PL169045B1 (pl) 1996-05-31
EP0592594B1 (de) 1998-12-02
SK194A3 (en) 1994-11-09
CZ286958B6 (cs) 2000-08-16
FI935943L (fi) 1993-12-30
HU222242B1 (hu) 2003-05-28
KR100240362B1 (ko) 2000-02-01
ATE173931T1 (de) 1998-12-15
JPH06509097A (ja) 1994-10-13
ES2124736T3 (es) 1999-02-16
CA2110166C (en) 2002-11-05
CA2110166A1 (en) 1993-01-21
HU9400004D0 (en) 1994-05-30
US5490987A (en) 1996-02-13
NO940008L (no) 1994-01-03
DE69227773T2 (de) 1999-05-20
DK0592594T3 (da) 1999-08-16
HUT69394A (en) 1995-09-28
NO940008D0 (no) 1994-01-03
FI935943A0 (fi) 1993-12-30
EP0592594A1 (de) 1994-04-20

Similar Documents

Publication Publication Date Title
NO307686B1 (no) Farmasøytisk tablett med høy styrke inneholdende colestipolhydroklorid og fremgangsmåte for fremstilling av tabletter
US5100675A (en) Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine
EP1258245A3 (de) Bromocriptin enthaltende Zusammensetzung mit beschleunigter Freisetzung
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
CA2456604A1 (en) Pharmaceutical composition comprising lumiracoxib
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
NO933321L (no) NADH og NADPH som legemiddel til behandling av Mobus Alzheimer
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
Plante et al. Dipyridamole-aspirin versus low doses of heparin in the prophylaxis of deep venous thrombosis in abdominal surgery
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
ES2087915T3 (es) Agente terapeutico y procedimiento que inhibe la vascularizacion de tumores.
ES2042831T3 (es) Procedimiento de preparacion de una composicion farmaceutica para el tratamiento de la osteoporosis.
Pitkeathly et al. Indomethacin in in-patient treatment of rheumatoid arthritis
Russell Jr et al. Implications of the phenomenon of open cavity healing for the chemotherapy of pulmonary tuberculosis
Ockelford et al. A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery
CA2184361C (en) Solid dose forms containing bismuth
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
EP0681476B1 (de) Wismutsubsalicylat in form einer einheitsdosis
US4522827A (en) Method of treating acute pancreatitis with isometheptene
Segal et al. A polyamine formaldehyde resin IV. Clinical evaluation in the treatment of duodenal ulcer
US5081129A (en) Method of treatment of anemia with seratonin antagonists
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
RU2019161C1 (ru) Средство профилактики острых приступов глаукомы при геомагнитных бурях
NO961046L (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre

Legal Events

Date Code Title Description
MK1K Patent expired